Movement Alert｜GenScript Biotech Falls 5.01% in Regular Trading, Profit-Taking After ASCO Catalyst Combines with Sector Weakness

Market Focus05-28

On May 28, GenScript Biotech fell 5.01% in regular trading, trading at HKD 14.39/share, with trading volume of HKD 101 million.

On the news front, the stock had surged over 5% in the prior session after its associate company Legend Biotech announced multiple research results at the ASCO annual meeting, including Phase 1 clinical data for LB2102, a DLL3-targeting CAR-T therapy for relapsed or refractory small cell lung cancer, along with new CARVYKTI data. The current decline appears driven by profit-taking following the prior session's rally on the ASCO catalyst.

Additionally, Hong Kong Stock Connect channels had seen consecutive days of significant net outflows prior to this session, raising market concerns over institutional selling into the strength. Within the Life Sciences Tools & Services sector, broad weakness prevailed, with Wuxi AppTec down 3.2%, Wuxi Biologics down 3.68%, Wuxi XDC down 5.85%, and Insilico down 3.49%, further pressuring sentiment across the space.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1140864170?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-28 11:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1140864170","market":"us","top_or_hot":-1,"title":"Movement Alert｜GenScript Biotech Falls 5.01% in Regular Trading, Profit-Taking After ASCO Catalyst Combines with Sector Weakness","media":"Market Focus","content":"<p><p>On May 28, GenScript Biotech fell 5.01% in regular trading, trading at HKD 14.39/share, with trading volume of HKD 101 million.</p><p>On the news front, the stock had surged over 5% in the prior session after its associate company Legend Biotech announced multiple research results at the ASCO annual meeting, including Phase 1 clinical data for LB2102, a DLL3-targeting CAR-T therapy for relapsed or refractory small cell lung cancer, along with new CARVYKTI data. The current decline appears driven by profit-taking following the prior session's rally on the ASCO catalyst.</p><p>Additionally, Hong Kong Stock Connect channels had seen consecutive days of significant net outflows prior to this session, raising market concerns over institutional selling into the strength. Within the Life Sciences Tools & Services sector, broad weakness prevailed, with Wuxi AppTec down 3.2%, Wuxi Biologics down 3.68%, Wuxi XDC down 5.85%, and Insilico down 3.49%, further pressuring sentiment across the space.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜GenScript Biotech Falls 5.01% in Regular Trading, Profit-Taking After ASCO Catalyst Combines with Sector Weakness</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜GenScript Biotech Falls 5.01% in Regular Trading, Profit-Taking After ASCO Catalyst Combines with Sector Weakness\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-05-28 11:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On May 28, GenScript Biotech fell 5.01% in regular trading, trading at HKD 14.39/share, with trading volume of HKD 101 million.</p><p>On the news front, the stock had surged over 5% in the prior session after its associate company Legend Biotech announced multiple research results at the ASCO annual meeting, including Phase 1 clinical data for LB2102, a DLL3-targeting CAR-T therapy for relapsed or refractory small cell lung cancer, along with new CARVYKTI data. The current decline appears driven by profit-taking following the prior session's rally on the ASCO catalyst.</p><p>Additionally, Hong Kong Stock Connect channels had seen consecutive days of significant net outflows prior to this session, raising market concerns over institutional selling into the strength. Within the Life Sciences Tools & Services sector, broad weakness prevailed, with Wuxi AppTec down 3.2%, Wuxi Biologics down 3.68%, Wuxi XDC down 5.85%, and Insilico down 3.49%, further pressuring sentiment across the space.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01548","symbol_name":"金斯瑞生物科技","start_time":0,"source_url":"","article_id":"1140864170","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1140864170","pubTimestamp":1779938955,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On May 28, GenScript Biotech fell 5.01% in regular trading, trading at HKD 14.39/share, with trading volume of HKD 101 million.On the news front, the stock had surged over 5% in the prior session...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01548":"金斯瑞生物科技"},"translate_title":"动向提示|金斯瑞生物常规交易跌5.01%ASCO催化剂叠加板块疲软后获利回吐","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01548":1},"content_text":"On May 28, GenScript Biotech fell 5.01% in regular trading, trading at HKD 14.39/share, with trading volume of HKD 101 million.On the news front, the stock had surged over 5% in the prior session after its associate company Legend Biotech announced multiple research results at the ASCO annual meeting, including Phase 1 clinical data for LB2102, a DLL3-targeting CAR-T therapy for relapsed or refractory small cell lung cancer, along with new CARVYKTI data. The current decline appears driven by profit-taking following the prior session's rally on the ASCO catalyst.Additionally, Hong Kong Stock Connect channels had seen consecutive days of significant net outflows prior to this session, raising market concerns over institutional selling into the strength. Within the Life Sciences Tools & Services sector, broad weakness prevailed, with Wuxi AppTec down 3.2%, Wuxi Biologics down 3.68%, Wuxi XDC down 5.85%, and Insilico down 3.49%, further pressuring sentiment across the space.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1140864170","isCrawlerRequest":true}